Company intelligence / Profile preview

HoloCare

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

HoloCare’s AI-driven mixed reality platform enables clinicians to generate patient-specific 3D holograms from CT/MRI scans, improving pre-operative planning, intraoperative navigation, and multidisciplinary team discussions. The technology is clinically validated for liver surgery with ongoing expansion into other organs. Early results suggest improved surgical precision, reduced complications, shorter recovery times, and more efficient care coordination.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy (mixed reality surgical planning and navigation)
Industry: Surgical Medical Devices

Partnerships

Oslo University HospitalSopra SteriaSt. Olavs Hospital/SINTEF Trondheim

Beyond the preview

Go deeper on HoloCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HoloCare.

Explore the full profile